Kaylite cream (Hydroquinone, Mometasone, and Tretinoin) is mainly used to treat pigmentation problems like melasma and is not usually recommended for making the skin fairer and smoother over the long term. Although it may make the skin look lighter and smoother for some time, continuous use without a doctor?s advice can harm the skin. The mometasone in the cream is a steroid, and using it on the face for a long time may cause thinning of the skin, pimples, redness, burning, increased sensitivity, and visible veins. Hydroquinone may also cause patchy or uneven skin colour if used for too long. Tretinoin can make the skin dry, irritated, and more sensitive to sunlight. For naturally healthy and glowing skin, it is safer to follow a simple skincare routine. Use a gentle cleanser, moisturiser, and sunscreen daily, and drink enough water. Products containing vitamin C, niacinamide, or mild retinoid may help improve skin texture and brightness more safely. It is best to consult a dermatologist before continuing to use Kaylite cream regularly.

Kaylite cream contains hydroquinone, mometasone, and tretinoin. This combination is usually prescribed to reduce dark spots and pigmentation caused by melasma, not for long-term acne (pimple) treatment. Using it continuously for 2 years without medical supervision may not be safe. Mometasone is a steroid, and prolonged use on the face may worsen acne, thin the skin, increase redness, and cause small visible blood vessels or steroid-related pimples. Tretinoin may help reduce acne by unclogging pores. Hydroquinone may help lighten acne marks, but it is not meant for regular long-term use. For forehead acne, it is important to keep the skin clean, avoid oily hair products, wash the face gently twice daily, and avoid touching or squeezing pimples. A mild acne treatment containing adapalene, benzoyl peroxide, or salicylic acid may be more suitable, depending on the severity of your acne. You should consult a dermatologist to review your current cream and choose a safer long-term acne treatment plan.